Viewing Study NCT06502509



Ignite Creation Date: 2024-10-26 @ 3:34 PM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06502509
Status: COMPLETED
Last Update Posted: None
First Post: 2024-02-07

Brief Title: Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study
Sponsor: None
Organization: None

Study Overview

Official Title: How Does Kombucha Tea Improve Difficulty During Defecation in Patients With Schizophrenia- A Randomized Double-blinded Placebo-controlled Parallel Study
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients with schizophrenia frequently have difficulties in bowel habits due to medical adverse effects and unhealthy lifestyle and the use of various interventions to ameliorate the problems have been noted in clinical setting Probiotics including Kombucha tea have been proved to modulate the human gut microbiota which may help to improve the stool passage and have been attracting the public attention across the world However little is known among the patients with schizophrenia In the present study the research team intends to evaluate effectiveness of Kombucha tea when used in the clinical settings
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None